Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Teva Branded Pharmaceutical Products R&D LLC
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The participant has a diagnosis of active or stable vitiligo for at least 3 months.
The participant has a body mass index (BMI) within the range of 18.5 to 40.0 kg/m2
The participant is capable of giving signed, informed consent
The participant agrees to discontinue all agents and procedures used to treat vitiligo during the treatment period in the trial
If receiving permitted concomitant medications for any reason other than vitiligo, the participant must be on a stable regimen,
The participant must agree to avoid prolonged exposure to the sun, must use sunscreen, and must not use tanning booths, sun lamps, or other ultraviolet light sources
NOTE - Additional criteria apply, please contact the investigator for more information
You may not be if
The participant suffers from vitiligo induced by exposure to chemicals or immunotherapy known to induce vitiligo
The participant has other autoimmune diseases for which systemic immunotherapy is or may be warranted
The participant has current or history of malignancy or treatment of malignancy in the last 5 years, excluding fully-treated basal cell carcinoma
Infectious disease
The participant has used skin bleaching treatments for past treatment of vitiligo or other pigmented areas
The participant has a history of melanocyte-keratinocyte transplantation procedure or other surgical treatment for vitiligo. After 2 or more years since last melanocyte-keratinocyte transplantation procedure, the participants may be included in the trial.
The participant has donated or received any blood or blood products (white blood cells, platelets, etc) within the 60 days prior to screening or has donated blood or blood products on 2 or more occasions within the 6 months prior to IMP administration, or has donated plasma within 7 days before the screening visit, or has planned donations during the trial
The participant has current or history of alcohol or other substance abuse
NOTE- Additional criteria apply, please contact the investigator for more information
